Log In
BCIQ
Print this Print this
 

M207 (formerly ZP-Triptan)

  Manage Alerts
Collapse Summary General Information
Company Zosano Pharma Corp.
DescriptionZolmitriptan, a serotonin (5-HT1B) and 5-HT1D receptor agonist, delivered using Zosano's microneedle patch system
Molecular Target Serotonin (5-HT1B) receptor ; Serotonin (5-HT1D) receptor
Mechanism of ActionSerotonin (5-HT) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationMigraine
Indication DetailsTreat acute migraine
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today